Literature DB >> 17998940

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

I Martinez1, A S Gardiner, K F Board, F A Monzon, R P Edwards, S A Khan.   

Abstract

Human papillomaviruses (HPVs) are involved in the pathogenesis of cancer of the cervix (CaCx). MicroRNA (miRNA) expression analysis using Ambion (Austin, TX, USA) arrays showed that three miRNAs were overexpressed and 24 underexpressed in cervical cell lines containing integrated HPV-16 DNA compared to the normal cervix. Furthermore, nine miRNAs were overexpressed and one underexpressed in integrated HPV-16 cell lines compared to the HPV-negative CaCx cell line C-33A. Based on microarray and/or quantitative real-time PCR and northern blot analyses, microRNA-218 (miR-218) was specifically underexpressed in HPV-positive cell lines, cervical lesions and cancer tissues containing HPV-16 DNA compared to both C-33A and the normal cervix. Expression of the E6 oncogene of high-risk HPV-16, but not that of low-risk HPV-6, reduced miR-218 expression, and conversely, RNA interference of E6/E7 oncogenes in an HPV-16-positive cell line increased miR-218 expression. We also demonstrate that the epithelial cell-specific marker LAMB3 is a target of miR-218. We also show that LAMB3 expression is increased in the presence of the HPV-16 E6 oncogene and this effect is mediated through miR-218. These findings may contribute to a better understanding of the molecular mechanisms involved in cervical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998940      PMCID: PMC2447163          DOI: 10.1038/sj.onc.1210919

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

Review 1.  The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

Authors:  M Thomas; D Pim; L Banks
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

2.  Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.

Authors:  Timothy D Culp; Lynn R Budgeon; M Peter Marinkovich; Guerrino Meneguzzi; Neil D Christensen
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  microRNAs exhibit high frequency genomic alterations in human cancer.

Authors:  Lin Zhang; Jia Huang; Nuo Yang; Joel Greshock; Molly S Megraw; Antonis Giannakakis; Shun Liang; Tara L Naylor; Andrea Barchetti; Michelle R Ward; George Yao; Angelica Medina; Ann O'brien-Jenkins; Dionyssios Katsaros; Artemis Hatzigeorgiou; Phyllis A Gimotty; Barbara L Weber; George Coukos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

4.  The colorectal microRNAome.

Authors:  Jordan M Cummins; Yiping He; Rebecca J Leary; Ray Pagliarini; Luis A Diaz; Tobias Sjoblom; Omer Barad; Zvi Bentwich; Anna E Szafranska; Emmanuel Labourier; Christopher K Raymond; Brian S Roberts; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

5.  Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.

Authors:  Yaguang Xi; Reut Shalgi; Oystein Fodstad; Yitzhak Pilpel; Jingfang Ju
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

6.  Laminin-5 as a marker of invasiveness in cervical lesions.

Authors:  B Skyldberg; S Salo; E Eriksson; U Aspenblad; B Moberger; K Tryggvason; G Auer
Journal:  J Natl Cancer Inst       Date:  1999-11-03       Impact factor: 13.506

Review 7.  MicroRNA-cancer connection: the beginning of a new tale.

Authors:  George Adrian Calin; Carlo Maria Croce
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

8.  The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.

Authors:  Shuang Tang; Mingfang Tao; J Philip McCoy; Zhi-Ming Zheng
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

9.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.

Authors:  Ivan Martinez; Jun Wang; Kenosha F Hobson; Robert L Ferris; Saleem A Khan
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

10.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.

Authors:  E Bandrés; E Cubedo; X Agirre; R Malumbres; R Zárate; N Ramirez; A Abajo; A Navarro; I Moreno; M Monzó; J García-Foncillas
Journal:  Mol Cancer       Date:  2006-07-19       Impact factor: 27.401

View more
  150 in total

1.  MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.

Authors:  Xiao He; Xia Xiao; Lin Dong; Nengbin Wan; Zhengyu Zhou; Hongwu Deng; Xiefu Zhang
Journal:  Tumour Biol       Date:  2014-11-15

Review 2.  MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Authors:  Rachel C Blitzblau; Joanne B Weidhaas
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

3.  Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection.

Authors:  Gerard J Nuovo; Xin Wu; Stefano Volinia; Fengting Yan; Gianpiero di Leva; Nena Chin; Alcina F Nicol; Jinmai Jiang; Gregory Otterson; Thomas D Schmittgen; Carlo Croce
Journal:  Diagn Mol Pathol       Date:  2010-09

Review 4.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

Review 5.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

6.  MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium.

Authors:  Frank Schembri; Sriram Sridhar; Catalina Perdomo; Adam M Gustafson; Xiaoling Zhang; Ayla Ergun; Jining Lu; Gang Liu; Xiaohui Zhang; Jessica Bowers; Cyrus Vaziri; Kristen Ott; Kelly Sensinger; James J Collins; Jerome S Brody; Robert Getts; Marc E Lenburg; Avrum Spira
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-23       Impact factor: 11.205

Review 7.  Hepatitis viruses and non-Hodgkin's lymphoma: A review.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Rudragoud S Policegoudra; Hemant K Gogoi; Lokendra Singh
Journal:  World J Virol       Date:  2012-12-12

8.  Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a.

Authors:  Vanessa Villegas-Ruiz; Sergio Juárez-Méndez; Oscar A Pérez-González; Hugo Arreola; Lucero Paniagua-García; Miriam Parra-Melquiadez; Raúl Peralta-Rodríguez; Ricardo López-Romero; Alberto Monroy-García; Alejandra Mantilla-Morales; Guillermo Gómez-Gutiérrez; Edgar Román-Bassaure; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.

Authors:  Xinqi He; Yujuan Dong; Chung Wah Wu; Zengren Zhao; Simon S M Ng; Francis K L Chan; Joseph J Y Sung; Jun Yu
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

10.  A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Authors:  Ling Lian; Lujiang Qu; Yanmei Chen; Susan J Lamont; Ning Yang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.